For the Inventor, By the Inventor

Enter assignee name

Tokyo-to, Japan

Meiji Seika Kaisha, Ltd.

USPTO Granted Patents = 382

CIPO Patents = 7

EPO Patents = 13

Trademarks = 9

Forward Citations = 3,553

Loading Chart...

Loading Chart...

748 inventors (with patents filed for the assignee):

Shigeharu Inouye (39 out of 49 patents)

Takashi Tsuruoka (39 out of 52 patents)

Seiji Shibahara (29 out of 44 patents)

4. Takashi Shomura (29 out of 29 patents)

5. Taro Niida (27 out of 35 patents)

6. Katsuyoshi Iwamatsu (24 out of 33 patents)

7. Kunio Atsumi (23 out of 32 patents)

8. Shinichi Kondo (16 out of 130 patents)

9. Keizo Mochizuki (16 out of 17 patents)

10. Manabu Watanabe (15 out of 46 patents)

11. Keiichi Ajito (15 out of 16 patents)

12. Yasushi Murai (14 out of 19 patents)

13. Kiyoaki Katano (14 out of 24 patents)

14. Masao Koyama (14 out of 26 patents)

15. Shigeo Seki (14 out of 17 patents)

Core Competencies:

Aminoglycoside Antibiotics

Metallo-Beta-Lactamase Inhibitors

Carbapenem Derivatives

Agricultural Disease Control Agents

Antibacterial Agents

Lincosamide Derivatives

Tyrosinase Activity Inhibitor

Therapeutic Agents for Inflammatory Bowel Diseases

Pest Control Agents

Saponin-Decomposing Enzyme

Functional Foods and Drinks

Cellulase Resistant to Surfactants

382 patents: Sort by Forward Citations

1. 9469863 - Aminoglycoside antibiotics, process for producing the same, and pharmaceutical use thereof (2016-10-18),

2. 9260375 - Metallo-β-lactamase inhibitors (2016-02-16),

3. 8344154 - 2-thioethenyl substituted carbapenem derivatives (2013-01-01),

4. 8324427 - Substances analogous to MK8383 and agricultural and horticultural disease control agents (2012-12-04),

5. 8097708 - 10a-Azalide compound (2012-01-17),

6. 8093294 - Metallo-β-lactamase inhibitors (2012-01-10),

7. 8084044 - [object Object] (2011-12-27),

8. 8071153 - Whey protein-containing granules and method of producing the same (2011-12-06),

9. 8058247 - Antibacterial agent and therapeutic agent for johne's disease containing the same (2011-11-15),

10. 8030052 - Midecamycin hyper producing strain (2011-10-04),

11. 8017797 - Method for producing phosphorus-containing α-keto acid (2011-09-13),

12. 7955789 - Adhesion-preventing material and process for preventing adhesion (2011-06-07),

13. 7910575 - Prophylactic or therapeutic agents for allergic ophthalmic diseases or allergic nasal diseases, comprising tricyclic triazolobenzazepine derivative (2011-03-22),

14. 7910089 - Sialogogue, oral composition and food product containing the same (2011-03-22),

15. 7893254 - Process for production of 3-alkenylcephem compounds (2011-02-22),

Meiji Seika Kaisha, Ltd. is a Japanese pharmaceutical and confectionery company established in 1916. With a focus on health and well-being, Meiji offers a wide range of products including pharmaceuticals, dairy products, snacks, confectioneries, and sports nutrition. Headquartered in Tokyo, Meiji is committed to innovation, quality, and customer satisfaction.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

382 Patents

#4 in Tokyo-to

#437 in Japan

#2,347 in the World

Tokyo-to, Japan

Meiji Seika Kaisha, Ltd.

Forward Citations = 3,553

748 inventors:

Shigeharu Inouye (39 out of 49 patents)

Takashi Tsuruoka (39 out of 52 patents)

Seiji Shibahara (29 out of 44 patents)

4. Takashi Shomura (29 out of 29 patents)

5. Taro Niida (27 out of 35 patents)

Please report any incorrect information to support@idiyas.com

Loading…